(Q40975113)

25 September 2017

title

Unsymmetric nonpeptidic HIV protease inhibitors containing anthranilamide as a P2' ligand (English)

1 reference

25 September 2017

Randad RS

1

1 reference

25 September 2017

Lubkowska L

2

1 reference

25 September 2017

Eissenstat MA

3

1 reference

25 September 2017

Gulnik SV

4

1 reference

25 September 2017

Yu B

5

1 reference

25 September 2017

Bhat TN

6

1 reference

25 September 2017

Clanton DJ

7

1 reference

25 September 2017

House T

8

1 reference

25 September 2017

Stinson SF

9

1 reference

25 September 2017

Erickson JW

10

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

Bioorganic & Medicinal Chemistry Letters

25 September 2017

published in

1 reference

25 September 2017

volume

8

1 reference

25 September 2017

issue

24

1 reference

25 September 2017

page(s)

3537-3542

1 reference

A structural model for the retroviral proteases.

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900657-X

7 January 2021

Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900657-X

7 January 2021

Symmetry-based inhibitors of HIV protease. Structure-activity studies of acylated 2,4-diamino-1,5-diphenyl-3-hydroxypentane and 2,5-diamino-1,6-diphenylhexane-3,4-diol

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900657-X

7 January 2021

Design of orally bioavailable, symmetry-based inhibitors of HIV protease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900657-X

7 January 2021

In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900657-X

7 January 2021

New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900657-X

7 January 2021

Discovery of ritonavir, a potent inhibitor of HIV protease with high oral bioavailability and clinical efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900657-X

7 January 2021

10.1016/S0960-894X(98)00657-X

Identifiers

DOI

1 reference

25 September 2017

1 reference